Atlanta, GA, United States of America

Lei Deng

This inventor holds 1 USPTO granted patent. Top assignee: The Georgia State University Research Foundation, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Deng. Retrieved from https://idiyas.com/inventor/lei-deng-s638wmri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lei Deng: Innovator in Influenza Vaccine Development

Introduction

Lei Deng is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of vaccine development, particularly in the area of influenza. Her innovative work focuses on creating a universal influenza vaccine that could potentially revolutionize how we combat this widespread virus.

Latest Patents

Lei Deng holds a patent for a "Headless Hemagglutinin Influenza Vaccine." This patent discloses a universal influenza vaccine based on a truncated influenza hemagglutinin (HA) protein that lacks a head domain (hrHA). Additionally, the patent includes compositions comprising a nanoparticle coated with the hrHA polypeptide and a virus-like particle (VLP) that expresses the hrHA polypeptide on its surface. This innovative approach aims to enhance the effectiveness of influenza vaccines.

Career Highlights

Lei Deng is affiliated with the Georgia State University Research Foundation, Inc. Her work at this institution has allowed her to focus on groundbreaking research in vaccine technology. She has dedicated her career to improving public health through innovative solutions in immunology.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Lei Deng's contributions to the field of influenza vaccine development highlight her role as a leading inventor in the medical research community. Her innovative approaches have the potential to significantly impact public health and advance vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…